Clinical Trial

The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain

Study acronym: PoB-EP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated February 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investigates how belief and expectation influence empathic pain-the pain we feel when observing others in distress. Healthy adult participants will be randomly assigned to one of three groups: no-treatment control, placebo nasal spray, oxytocin-containing nasal spray. Participants in both the placebo and oxytocin conditions will be informed that they are receiving oxytocin, described as a potent agent for pain relief. During functional MRI scanning, all participants will view naturalistic pain-related videos and provide ratings of perceived subjective pain. The study aims to examine how cognitive beliefs and neuromodulatory interventions alter subjective pain experience and brain activity, including changes in brain network communication.
Trial Details
NCT Number NCT07367672
Lead Sponsor University of Electronic Science and Technology of China
Conditions Healthy Participants
Enrollment 120 participants
Start Date 2025-12-01
Primary Completion 2026-02-20 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-26